MedTrace Logo

Effects of Pectin Supplementation in Diarrhea-predominant Irritable Bowel Syndrome

NCT02270268 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2016-03-24

No results posted yet for this study

Summary

The purpose of this study is to investigate the effect of pectin, a kind of soluble dietary fiber, on clinical symptoms, gut microbiota and the immune status in patients with diarrhea-predominant irritable bowel syndrome

Conditions

  • Irritable Bowel Syndrome

Interventions

DIETARY_SUPPLEMENT

Pectin

Pectin （Andeli Ltd. Yantai, China）, 24g/d for six weeks

DIETARY_SUPPLEMENT

maltodextrin

Sponsors & Collaborators

  • Nanjing PLA General Hospital

    lead OTHER

Principal Investigators

  • Tao Gao, M.D. · Nanjing PLA General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2013-10-31
Completion
2013-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02270268 on ClinicalTrials.gov